Monitor PRECURSOR demonstration reactor completion by end of 2026 and subsequent validation results, as well as progress on U.S. NRC licensing engagements for both the reactor and MOX fuel facility. Cash runway of ~€233M post-SPAC provides multi-year funding visibility for a pre-revenue nuclear technology company.
Price Chart
Executive Summary
newcleo reported first half 2026 revenue of €19.4M (+46% YoY) and a net loss of €82.0M (widening 10% YoY). The company completed its SPAC business combination on September 21, 2026, raising ~$247M in gross proceeds, and ended September with ~€233M in cash. The filing is a first public earnings report post-listing, with no analyst consensus available for comparison.
Key Financial Metrics
Key Facts
- Revenue from Products and Services of €19.4M for H1 2026, up 46% YoY from €13.3M
- Net loss of €82.0M for H1 2026, widening 10% YoY from €74.3M
- Gross profit of €6.1M, up 48% YoY from €4.2M
- Cash & cash equivalents of €66.5M as of June 30, 2026; preliminary unaudited cash of ~€233M as of September 30, 2026
- Completed SPAC business combination on September 21, 2026, raising ~$247M gross proceeds ($31M from trust + $216M PIPE)
- Raised ~€18.7M in additional financing since May 2026, bringing total funds raised since founding to over $1B
- PRECURSOR non-nuclear demonstration reactor construction expected to complete by end of 2026
- Submitted Regulatory Engagement Plans to U.S. NRC for LFR-AS-200 reactor and planned MOX fuel facility
- Received satisfactory safety opinion from French ASNR for planned MOX fuel manufacturing facility
- Appointed Jeffrey Lyash (former TVA CEO) as Chairman and William D. Magwood as Vice-Chairman of the Board
- Basic and diluted loss per share of €0.16 for H1 2026; restated to $(0.34) post-business combination
Financial Impact
Revenue €19.4M (+46% YoY), net loss €82.0M (+10% YoY), cash post-SPAC ~€233M
Risk Factors
- Pre-revenue company with widening net losses and no near-term commercial reactor revenue
- Regulatory and licensing timelines for advanced nuclear reactors are uncertain and subject to delays
- Execution risk on PRECURSOR demonstration and subsequent LFR-200 commercial deployment
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3373843 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 8d ago | EFFECT | $4.75 $4.32 | ▲ +9.16% | ▲ +9.01% | $4.40 (+7.37%) |
Oct 15, 2026 12d ago | SC 13G | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 15, 2026 12d ago | SC 13G | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 14, 2026 13d ago | 6-K | $6.37 $4.25 | ▼ −33.36% | ▼ −32.34% | $4.40 (−30.93%) |
Oct 6, 2026 21d ago | F-1 | $7.91 $6.31 | ▲ +20.23% | ▲ +19.25% | $4.40 (+44.37%) |
Oct 6, 2026 21d ago | 6-K | $7.91 $6.31 | ▼ −20.23% | ▼ −19.25% | $4.40 (−44.37%) |
Oct 5, 2026 22d ago | 6-K | $8.53 $7.37 | ▲ +13.60% | ▲ +14.02% | $4.40 (+48.42%) |
Oct 2, 2026 25d ago | Press Release | $7.99 $7.47 | ▼ −6.51% | ▼ −7.67% | $4.40 (−44.93%) |
Sep 25, 2026 4w ago | 6-K | $7.60 $8.53 | ▲ +12.24% | ▲ +11.03% | $4.40 (−42.11%) |
Sep 22, 2026 5w ago | 6-K | $7.83 $7.85 | ▲ +0.26% | ▲ +0.93% | $4.40 (−43.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers